ID24933A - COMBINATION OF ACTIVE COMPONENTS FOR THE SENILE DEMENTIA TREATMENTS OF TYPES OF ALZHEIMER - Google Patents

COMBINATION OF ACTIVE COMPONENTS FOR THE SENILE DEMENTIA TREATMENTS OF TYPES OF ALZHEIMER

Info

Publication number
ID24933A
ID24933A IDW20000860A ID20000860A ID24933A ID 24933 A ID24933 A ID 24933A ID W20000860 A IDW20000860 A ID W20000860A ID 20000860 A ID20000860 A ID 20000860A ID 24933 A ID24933 A ID 24933A
Authority
ID
Indonesia
Prior art keywords
alzheimer
types
combination
active components
senile dementia
Prior art date
Application number
IDW20000860A
Other languages
Indonesian (id)
Inventor
Jean-Pierre Maffrand
Philippe Soubrie
Jean-Paul Terranova
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9714324A external-priority patent/FR2771006B1/en
Priority claimed from FR9714322A external-priority patent/FR2771007B1/en
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of ID24933A publication Critical patent/ID24933A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDW20000860A 1997-11-14 1998-11-09 COMBINATION OF ACTIVE COMPONENTS FOR THE SENILE DEMENTIA TREATMENTS OF TYPES OF ALZHEIMER ID24933A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714324A FR2771006B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FR9714322A FR2771007B1 (en) 1997-11-14 1997-11-14 COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE

Publications (1)

Publication Number Publication Date
ID24933A true ID24933A (en) 2000-08-31

Family

ID=26233932

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000860A ID24933A (en) 1997-11-14 1998-11-09 COMBINATION OF ACTIVE COMPONENTS FOR THE SENILE DEMENTIA TREATMENTS OF TYPES OF ALZHEIMER

Country Status (27)

Country Link
EP (1) EP1030671A1 (en)
JP (1) JP2001523642A (en)
KR (1) KR100599350B1 (en)
CN (1) CN1243540C (en)
AU (1) AU743228B2 (en)
BG (1) BG64819B1 (en)
BR (1) BR9814035A (en)
CA (1) CA2309966A1 (en)
CO (1) CO4980891A1 (en)
DZ (1) DZ2649A1 (en)
EA (1) EA003255B1 (en)
EE (1) EE04235B1 (en)
HU (1) HUP0100098A3 (en)
ID (1) ID24933A (en)
IL (2) IL136122A0 (en)
IS (1) IS5482A (en)
MY (1) MY120461A (en)
NO (1) NO20002450L (en)
NZ (1) NZ504420A (en)
OA (1) OA11464A (en)
PL (1) PL194597B1 (en)
SA (1) SA98190747B1 (en)
SK (1) SK286040B6 (en)
TR (1) TR200001262T2 (en)
TW (1) TW585766B (en)
UY (1) UY25247A1 (en)
WO (1) WO1999025363A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105830A1 (en) * 2002-06-14 2003-12-24 富山化学工業株式会社 Medicinal compositions improving brain function and method for improving brain function
US20060160079A1 (en) * 2002-08-07 2006-07-20 Lane Roger M Methods for the treatment of dementia based on apo e genotype
CN1520818A (en) * 2003-02-09 2004-08-18 ɽ����Ҷ��Ȼҩ���о��������޹�˾ Cholinesterase inhibitor pharmaceutical composition for treating senile dementia
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
AU2015210852B2 (en) 2014-01-31 2019-01-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
DK3634394T3 (en) 2017-05-15 2026-03-02 Cognition Therapeutics Inc COMPOSITIONS FOR TREATING NEUROGENERATE DISEASES
KR102224917B1 (en) 2018-03-20 2021-03-09 (주)인벤티지랩 Production methods of preventing or treating cognitive impairment-related disease and preventing or treating cognitive impairment-related disease producing thereto
WO2019182319A1 (en) * 2018-03-20 2019-09-26 (주)인벤티지랩 Method for preparing pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, and pharmaceutical composition for preventing or treating cognitive disorder-associated diseases, prepared by preparation method
CN109265391B (en) * 2018-11-13 2021-11-19 枣庄学院 Biphenyl polysubstituted 1,2,5, 6-tetrahydropyridine compound and synthetic method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (en) * 1990-05-22 1994-11-10 Sanofi Sa USE OF 1- [2- (2-NAPHTYL) ETHYL] -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETRAHYDROPYRIDINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF BRAIN AND NEURAL DISORDERS.
US5453428A (en) * 1991-02-14 1995-09-26 The Mount Sinai School Of Medicine Of The City Of New York Method and composition for the treatment of apathy-amotivation syndrome
CA2213000A1 (en) * 1995-03-06 1996-09-12 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
FR2736053B1 (en) * 1995-06-28 1997-09-19 Sanofi Sa NEWS 1-PHENYLALKYL-1,2,3,6-TETRAHYDROPYRIDINES

Also Published As

Publication number Publication date
BG64819B1 (en) 2006-05-31
PL194597B1 (en) 2007-06-29
EP1030671A1 (en) 2000-08-30
IL136122A (en) 2006-07-05
SA98190747B1 (en) 2006-11-04
MY120461A (en) 2005-10-31
DZ2649A1 (en) 2004-12-28
CA2309966A1 (en) 1999-05-27
IS5482A (en) 2000-05-09
JP2001523642A (en) 2001-11-27
PL340500A1 (en) 2001-02-12
AU743228B2 (en) 2002-01-24
OA11464A (en) 2003-11-18
EA200000412A1 (en) 2000-12-25
SK7112000A3 (en) 2000-10-09
KR100599350B1 (en) 2006-07-12
EE200000290A (en) 2001-06-15
IL136122A0 (en) 2001-05-20
BR9814035A (en) 2000-09-26
TW585766B (en) 2004-05-01
WO1999025363A1 (en) 1999-05-27
CO4980891A1 (en) 2000-11-27
UY25247A1 (en) 2001-05-31
CN1243540C (en) 2006-03-01
BG104428A (en) 2001-08-31
NO20002450D0 (en) 2000-05-11
NZ504420A (en) 2003-08-29
CN1285742A (en) 2001-02-28
HUP0100098A3 (en) 2001-12-28
HUP0100098A2 (en) 2001-07-30
NO20002450L (en) 2000-07-14
EE04235B1 (en) 2004-02-16
KR20010032099A (en) 2001-04-16
AU1160999A (en) 1999-06-07
EA003255B1 (en) 2003-02-27
TR200001262T2 (en) 2001-01-22
SK286040B6 (en) 2008-01-07

Similar Documents

Publication Publication Date Title
FI972584A0 (en) Substituted azetidin-2-ones for the treatment of atherosclerosis
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20004688D0 (en) Therapy for estrogen-associated disorders
DK0775100T3 (en) Process for the preparation of trifluoroethylene
NO20010456L (en) Triazolopyridines for the treatment of thrombosis disorders
NO20024060D0 (en) Process for the preparation of an oxazolylethanol derivative
HRP980097A2 (en) Combinatory compositions for the treatment of dementia
DZ2649A1 (en) Association of active principles for the treatment of senile dementia of the alzheimer type.
IS1919B (en) Benzamide for the treatment of neurodegenerative disorders
FI971199A0 (en) copolyesters
NO20003481D0 (en) Procedure for the treatment of COPD
NO996432D0 (en) Process for the preparation of 4-substituted-1H-indole-3-glycosamides
NO944577D0 (en) Inhibition of the effect of amyloidogenic proteins
NO993549D0 (en) Imino-aza-anthracycline derivatives for the treatment of amyloidosis
NO20014026L (en) Antispasmodic derivatives for the treatment of significant tremor
NO20003077D0 (en) Process for the preparation of the chlorobenzoxazole
NO994557D0 (en) Process for the preparation of arylaminotriazolopyridines
KR950030644U (en) Structure of the crypt box
ZA989955B (en) Combination of active ingredients for the treatment of senile dementia of the alzheimer type
NO20002476D0 (en) Process for the preparation of formylimidazoles
NO20011268D0 (en) Connection for the treatment of depression
NO930436D0 (en) PROCEDURE FOR PREPARING BATHROOMS
UA829S (en) HOUSING OF THE SPLITTER
FR2771007B1 (en) COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF SENILE DEMENTIA OF THE ALZHEIMER TYPE
FI944868A0 (en) For the purposes of this Regulation